ANTITRUST POLICY related term(s) Monopolies

Amendments

Courts: eliminate mandatory arbitration clauses in employment, consumer, civil rights, and antitrust cases (H.R. 1423), H7848, H7849, H7850 [20SE]

——— eliminate mandatory arbitration clauses in employment, consumer, civil rights, and antitrust cases (H.R. 1423), consideration (H. Res. 558), H7765 [18SE]

Bills and resolutions

Agriculture: impose a moratorium on large agribusiness, food and beverage manufacturing, and grocery retail mergers and establish a commission to review such mergers and antitrust oversight of farm and food sectors (see S. 1596), S3059 [22MY] (see H.R. 2933), H4119 [22MY]

Business and industry: modify standards for unlawful acquisitions (see S. 307), S800 [31JA]

——— promote merger enforcement and protect competition through adjusting premerger filing fees and increasing antitrust enforcement resources (see S. 1937), S4169 [20JN]

——— promote merger enforcement and protect competition through adjusting premerger filing fees, increasing antitrust enforcement resources, and improving information provided to antitrust enforcers (see S. 306), S800 [31JA]

CFTC: extend jurisdiction to include setting of reference prices for aluminum premiums (see S. 1953), S4504 [25JN] (see H.R. 1406), H2270 [27FE]

Courts: eliminate mandatory arbitration clauses in employment, consumer, civil rights, and antitrust cases (see S. 610), S1593 [28FE] (see H.R. 1423), H2311 [28FE]

——— eliminate mandatory arbitration clauses in employment, consumer, civil rights, and antitrust cases (H.R. 1423), consideration (see H. Res. 558), H7752 [17SE]

FTC: prohibit anticompetitive use of patents by drug product manufacturers (see S. 1416), S2770 [9MY] (see H.R. 4398), H7834 [19SE] (see H.R. 5133), H8958 [18NO]

Insurance: restore application of Federal antitrust laws to the business of health insurance to protect competition and consumers (see S. 350), S919 [6FE] (see H.R. 1418), H2311 [28FE]

Medicare: increase hospital competition (see H.R. 506), H517 [11JA]

Monopolies: make oil-producing and exporting cartels illegal (see S. 370), S1131 [7FE] (see H.R. 948), H1349 [4FE]

News media: provide a temporary safe harbor from antitrust laws for publishers of online content to collectively negotiate with dominant online platforms about terms on which their content may be distributed (see S. 1700), S3164 [3JN] (see H.R. 2054), H3067 [3AP]

Sherman Act: authorize Dept. of Justice and FTC to seek civil monetary penalties to deter certain violations (see S. 2237), S5012 [23JY]

Whistleblowing: provide anti-retaliation protections for antitrust whistleblowers (see S. 2258), S5063 [24JY]

Remarks in House

CFTC: extend jurisdiction to include setting of reference prices for aluminum premiums (H.R. 1406), H2242 [27FE]

Courts: clarify that provisions to eliminate mandatory arbitration clauses in employment, consumer, civil rights, and antitrust cases shall not prohibit option of voluntary arbitration between consenting parties, H7850, H7851 [20SE]

——— eliminate mandatory arbitration clauses in employment, consumer, civil rights, and antitrust cases (H.R. 1423), H7588–H7592 [10SE], H7690 [12SE], H7777, H7818 [19SE], H7840–H7853, H7858 [20SE], H7871 [24SE], H10080 [11DE]

——— eliminate mandatory arbitration clauses in employment, consumer, civil rights, and antitrust cases (H.R. 1423), consideration (H. Res. 558), H7761–H7767 [18SE]

——— prohibit mandatory binding arbitration contracts negotiated as part of collective bargaining agreement in employment, consumer, civil rights, and antitrust cases, H7849, H7850 [20SE]

Remarks in Senate

Courts: eliminate mandatory arbitration clauses in employment, consumer, civil rights, and antitrust cases (S. 610), S5864 [17OC]

FTC: prohibit anticompetitive use of patents by drug product manufacturers (S. 1416), S2870 [15MY], S3180 [4JN], S4488 [25JN], S4762, S4763 [10JY], S5009 [23JY], S5506 [17SE], S6217 [29OC], S6272 [30OC], S6368 [5NO], S6459 [7NO], S6497 [12NO], S6520–S6524, S6527 [13NO], S6640 [19NO], S6742 [21NO]

——— prohibit anticompetitive use of patents by drug product manufacturers (S. 1416), unanimous-consent request, S6521–S6523 [13NO], S6967, S6968 [11DE]

Whistleblowing: provide anti-retaliation protections for antitrust whistleblowers (S. 2258), S5071 [24JY], S5074 [25JY], S5904 [17OC]

Reports filed

Affordable Prescriptions for Patients Act: Committee on the Judiciary (Senate) (S. 1416), S4676 [28JN]

Consideration of H.R. 1423, Forced Arbitration Injustice Repeal (FAIR) Act: Committee on Rules (House) (H. Res. 558) (H. Rept. 116–210), H7752 [17SE]

Forced Arbitration Injustice Repeal (FAIR) Act: Committee on the Judiciary (House) (H.R. 1423) (H. Rept. 116–204), H7711 [13SE]

Texts of

H. Res. 558, consideration of H.R. 1423, Forced Arbitration Injustice Repeal (FAIR) Act, H7761 [18SE]

H.R. 1423, Forced Arbitration Injustice Repeal (FAIR) Act, H7848 [20SE]

S. 2288, Criminal Antitrust Anti-Retaliation Act, S5904 [17OC]